Clinical trial
Novel Biomarkers for Haemostasis in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome
NCT01525160 is registered in ClinicalTrials.gov with Hywel Dda Health Board as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Biomarkers for Haemostasis in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome
- Lead sponsor
- Hywel Dda Health Board
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- March 31, 2013
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biomarkers of fibrin clot structure, biomarkers of vascular endothelial injury, obstructive sleep apnoea hypopnoea syndrome